Showing results (361-370 of 372) with videos related to
Sort By:
Pageof 38
Nature Methods|September 6, 2011
Toward the blood-borne miRNome of human diseasesAndreas Keller, Petra Leidinger, Andrea Bauer, et al.Neuro-Oncology|December 29, 2019
Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumorsMichael C Frühwald, Martin Hasselblatt, Karolina Nemes, et al.Leukemia|August 22, 2019
Genotyping circulating tumor DNA of pediatric Hodgkin lymphomaAnn-Kathrin Desch, Kristin Hartung, Ante Botzen, et al.NPJ Precision Oncology|December 27, 2022
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORMHeike Peterziel, Nora Jamaladdin, Dina ElHarouni, et al.The Lancet. Oncology|June 27, 2024
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trialSelim Corbacioglu, Holger Lode, Susanne Ellinger, et al.Neuro-Oncology|September 30, 2025
Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registriesKatja von Hoff, Denise Obrecht-Sturm, David R Ghasemi, et al.Genome Medicine|June 25, 2016
Making sense of big data in health research: Towards an EU action planCharles Auffray, Rudi Balling, Inês Barroso, et al.Neuro-Oncology|May 8, 2024
Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profileGunther Nussbaumer, Martin Benesch, Yura Grabovska, et al.Cancer Discovery|August 10, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence TargetsCornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, et al.American Journal of Medical Genetics. Part A|February 8, 2017
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and HematologyTim Ripperger, Stefan S Bielack, Arndt Borkhardt, et al.Pageof 38